Risk factors for in-hospital mortality among children with tuberculosis: the 25-year experience in Peru

Peter C Drobac1, Sonya S Shin, Pedro Huamani

  • 1Partners In Health, Boston, Massachusetts 02115, USA. pdrobac@pih.org

Pediatrics
|July 25, 2012
PubMed

Insights

A negative tuberculin skin test (TST) strongly predicts death in children with tuberculosis (TB). Do not delay TB treatment in children with suspected TB, even with a negative TST result.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) remains a significant cause of mortality in children globally.
  • Predictors of in-hospital mortality among pediatric TB patients require further elucidation.
  • Tuberculin skin testing (TST) is a common diagnostic tool, but its predictive value for outcomes in children with TB is debated.

Purpose of the Study:

  • To identify factors associated with in-hospital death in children diagnosed with TB.
  • To investigate the hypothesis that a negative TST result predicts decreased survival in pediatric TB patients.

Main Methods:

  • Retrospective cohort study of 2392 children (0-14 years) hospitalized with TB in Peru over 25 years.
  • Detailed chart abstraction included clinical history, examination findings, diagnostic data, and treatment.
  • Cox proportional hazards regression analyses were used to determine risk factors for mortality.

Main Results:

  • The overall in-hospital mortality rate was 11% (266 deaths).
  • A negative TST (<5 mm induration) was a strong predictor of death (HR: 3.01; P < .0001).
  • Factors associated with mortality included younger age, altered mental status, respiratory distress, and peripheral edema. Rifampicin-containing regimens were associated with improved survival.

Conclusions:

  • A negative TST result is a highly significant predictor of mortality in children with active TB.
  • Clinical and radiographic findings suggestive of TB should prompt treatment initiation, irrespective of TST results.
  • Negative TST results should not delay or preclude anti-TB therapy in children with suspected TB.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: